Aytu Biopharma (AYTU) EBT Margin (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly EBT Margin of 45.19% for Q1 2026, down 6588.0% year-over-year from 0.7% in Q1 2025, and up 35.26% quarter-over-quarter from 69.79% in Q4 2025.
Aytu Biopharma (AYTU) EBT Margin (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported EBT Margin for 14 consecutive years, with 45.19% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin fell 6588.0% year-over-year to 45.19%; the TTM figure through Mar 2026 stood at 59.49% (down 6429.0% YoY), while the FY2025 annual figure was 20.71%, down 478.0% from the prior year.
- EBT Margin grew to 45.19% in Q1 2026 per AYTU's latest filing, from 69.79% in the prior quarter.
- Across five years, EBT Margin topped out at 20.69% in Q1 2025 and bottomed at 220.22% in Q1 2022.
- Historically, EBT Margin has averaged 35.78% across 5 years, with a median of 17.39% in 2024.
- Annual changes were most pronounced in 2023 — EBT Margin surged 18855 bps — and 2025, when it tumbled 11108 bps.
- Aytu Biopharma's EBT Margin stood at 25.47% in 2022, then jumped by 129 bps to 7.46% in 2023, then slumped by 68 bps to 2.35% in 2024, then sank by 3064 bps to 69.79% in 2025, then surged by 35 bps to 45.19% in 2026.
- Business Quant data shows AYTU's EBT Margin at 45.19% in Q1 2026, 69.79% in Q4 2025, and 14.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | -45.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.19% |
| Dec 31, 2025 | -69.79% |
| Sep 30, 2025 | 14.15% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 2.35% |
| Sep 30, 2024 | 9.04% |
| Jun 30, 2024 | -17.39% |
| Mar 31, 2024 | -12.60% |
| Dec 31, 2023 | 7.46% |
| Sep 30, 2023 | -41.94% |
| Jun 30, 2023 | -7.99% |
| Mar 31, 2023 | -31.67% |
| Dec 31, 2022 | -25.47% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -58.62% |
| Mar 31, 2022 | -220.22% |
| Dec 31, 2021 | -49.95% |
| Sep 30, 2021 | -127.68% |
| Jun 30, 2021 | -79.80% |